Bioorganic and Medicinal Chemistry Letters

Contributors to this Issue
pp. ix-xi(3)

Contents List
pp. iii

Graphical Abstracts
pp. 2053-2063(11)

Developing site-Specific immobilization strategies of peptides in a microarray
pp. 2079-2083(5)
Authors: Lesaicherre M.-L.; Uttamchandani M.; Chen G.Y.J.; Yao S.Q.

Antibody-Based fluorescence detection of kinase activity on a peptide array
pp. 2085-2088(4)
Authors: Lesaicherre M.-L.; Uttamchandani M.; Chen G.Y.J.; Yao S.Q.

4,4'-Benzophenone-O,O'-disulfamate: a potent inhibitor of steroid sulfatase
pp. 2093-2095(3)
Authors: Nussbaumer P.; Bilban M.; Billich A.

Synthesis and biological evaluation of N-(7-indolyl)-3-pyridinesulfonamide derivatives as potent antitumor agents
pp. 2097-2100(4)
Authors: Owa T.; Yoshino H.; Okauchi T.; Okabe T.; Ozawa Y.; Hata Sugi N.; Yoshimatsu K.; Nagasu T.; Koyanagi N.; Kitoh K.

Synthesis and hypoglycemic evaluation of substituted pyrazole-4-carboxylic acids
pp. 2105-2108(4)
Authors: Cottineau B.; Toto P.; Marot C.; Pipaud A.; Chenault J.

SAR of 2,6-diamino-3,5-difluoropyridinyl substituted heterocycles as novel p38MAP kinase inhibitors
pp. 2109-2112(4)
Authors: Revesz L.; Di Padova F.E.; Buhl T.; Feifel R.; Gram H.; Hiestand P.; Manning U.; Wolf R.; Zimmerlin A.G.

Pyrrolylquinoxalinediones carrying a piperazine residue represent highly potent and selective ligands to the homomeric kainate receptor GluR5
pp. 2113-2116(4)
Authors: Lubisch W.; Behl B.; Henn C.; Hofmann H.P.; Reeb J.; Regner F.; Vierling M.

Identification of the ability of highly charged nanomolar inhibitors of protein kinases to cross plasma membranes and carry a protein into cells
pp. 2117-2120(4)
Authors: Uri A.; Raidaru G.; Subbi J.; Padari K.; Pooga M.

Identification of a novel 1'-[5-((3,5-Dichlorobenzoyl)methylamino)-3-(3,4-dichlorophenyl)-4-(methoxyim ino)pentyl]-2-oxo-(1,4'-bipiperidine) as a Dual NK₁/NK₂ antagonist
pp. 2125-2128(4)
Authors: Ting P.C.; Lee J.F.; Shih N.-Y.; Piwinski J.J.; Anthes J.C.; Chapman R.W.; Rizzo C.A.; Hey J.A.; Ng K.; Nomeir A.A.

Rapid solid-Phase synthesis of DNA-Binding pyrrole-Imidazole polyamides
pp. 2129-2132(4)
Authors: Krutzik P.O.; Chamberlin A.R.

3-Aryl pyrazolo[4,3-d]pyrimidine derivatives - nonpeptide CRF-1 antagonists
pp. 2133-2136(4)
Authors: Yuan J.; Gulianello M.; De Lombaert S.; Brodbeck R.; Kieltyka A.; Hodgetts K.J.

N-(Arylacetyl)-biphenylalanines as Potent VLA-4 Antagonists
pp. 2141-2144(4)
Authors: Li B.; de Laszlo S.E.; Kamenecka T.; Kopka I.E.; Durette P.L.; Lanza J.; MacCoss M.; Tong S.; Mumford R.A.; McCauley E.; Van Riper G.; Schmidt J.A.; Hagmann W.K.

Novel thiophene derivatives for the treatment of benign prostatic hyperplasia
pp. 2145-2148(4)
Authors: Khatuya H.; Pulito V.L.; Jolliffe L.K.; Li X.; Murray W.V.

Improving metabolic stability of phosphodiesterase-4 inhibitors containing a substituted catechol: prevention of reactive intermediate formation and covalent binding
pp. 2149-2152(4)
Authors: Chauret N.; Guay D.; Li C.; Day S.; Silva J.; Blouin M.; Ducharme Y.; Yergey J.A.; Nicoll-Griffith D.A.

Antifungal activity of bifunctional sphingolipids. intramolecular synergism within long-chain ,-bis-aminoalcohols
pp. 2159-2162(4)
Authors: Nicholas G.M.; Li R.; MacMillan J.B.; Molinski T.F.

Synthesis and biological evaluation of 9-substituted tetracycline derivatives
pp. 2163-2165(3)
Authors: Koza D.J.; Nsiah Y.A.

Antimalarial compounds from Parinari capensis
pp. 2167-2169(3)
Authors: Uys A.C.U.; Malan S.F.; van Dyk S.; van Zyl R.L.

Design, synthesis, and biological evaluation of novel, centrally-Acting thyrotropin-Releasing hormone analogues
pp. 2171-2174(4)
Authors: Prokai-Tatrai K.; Perjesi P.; Zharikova A.D.; Li X.; Prokai L.

Synthesis and initial structure-Activity relationships of a novel series of imidazolo[1,2-a]pyrimid-5-ones as potent GnRH receptor antagonists
pp. 2179-2183(5)
Authors: Wilcoxen K.M.; Zhu Y.-F.; Connors P.J.; Saunders J.; Gross T.D.; Gao Y.; Reinhart G.J.; Struthers R.S.; Chen C.

Phosphonate and phosphinate analogues of N-Acylated -glutamylglutamate - potent inhibitors of glutamate carboxypeptidase II
pp. 2189-2192(4)
Authors: Tsukamoto T.; Flanary J.M.; Rojas C.; Slusher B.S.; Valiaeva N.; Coward J.K.

Design and synthesis of novel inhibitors of gelatinase B
pp. 2201-2204(4)
Authors: Wang X.; Choe Y.; Craik C.S.; Ellman J.A.

N-Aryl-prolyl-dipeptides as potent antagonists of VLA-4
pp. 2205-2208(4)
Authors: Kamenecka T.M.; Lanza J.; de Laszlo S.E.; Li B.; McCauley E.D.; Van Riper G.; Egger L.A.; Kidambi U.; Mumford R.A.; Tong S.; MacCoss M.; Schmidt J.A.; Hagmann W.K.

Synthesis and biological evaluation of 3'-Carboranyl thymidine analogues
pp. 2209-2212(4)
Authors: Yan J.; Naeslund C.; Al-Madhoun A.S.; Wang J.; Ji W.; Cosquer G.Y.; Johnsamuel J.; Sjoberg S.; Eriksson S.; Tjarks W.

Isothiazole dioxides: synthesis and inhibition of Trypanosoma brucei protein farnesyltransferase
pp. 2217-2220(4)
Authors: Clerici F.; Gelmi M.L.; Yokoyama K.; Pocar D.; Van Voorhis W.C.; Buckner F.S.; Gelb M.H.

Synthesis and antiparasitic activity of 1H-benzimidazole derivatives
pp. 2221-2224(4)
Authors: Valdez J.; Cedillo R.; Hernandez-Campos A.; Yepez L.; Hernandez-Luis F.; Navarrete-Vazquez G.; Tapia A.; Cortes R.; Hernandez M.; Castillo R.

Identification of a novel partial inhibitor of dopamine transporter among 4-substituted 2-phenylquinazolines
pp. 2225-2228(4)
Authors: Ananthan S.; Saini S.K.; Khare R.; Clayton S.D.; Dersch C.M.; Rothman R.B.